Maintaining a Healthy Lifestyle Decreases Risk for Peripheral Artery Disease
A prospective cohort study was conducted to determine the relationship between multiple modifiable lifestyle factors and risk for peripheral artery disease.
Peripheral Artery Disease
Peripheral Artery Disease in Acute Myocardial Infarction With Cardiogenic Shock
Researchers sought to determine the relationship between lower extremity peripheral artery disease and outcomes for acute myocardial infarction and cardiogenic shock.
Paclitaxel-Containing Devices Linked to Improved Survival at 2 Years
Researchers assessed the safety and efficacy of paclitaxel (PTX) devices for treating peripheral artery disease involving the femoropopliteal artery.
Younger Adults Admitted for Peripheral Vascular Disease With CV Comorbidities
Using 2 national cohorts 10 years apart, researchers compared the mean age of young adults, who were hospitalized for PVD with CV comorbidities and major adverse cardiac and cerebrovascular events.
PAD With Elevated ABI an Independent Risk Factor for Heart Failure
Researchers sought to determine if peripheral artery disease is an independent risk factor for heart failure.
High Remnant Cholesterol Linked to 5-Fold Increased Risk for PAD
Researchers aimed to determine if remnant cholesterol was associated with increased risk for peripheral artery disease.
Smoking Before Revascularization Raises Complication Risks
Researchers sought to assess whether smoking before open and endovascular revascularization for intermittent claudication increased risk for postprocedural complications.
Varenicline Combination, Extension No Better for Quitting Smoking
Combining varenicline with nicotine patch, extending treatment from 12 to 24 weeks did not increase smoking cessation rates
Higher-Dose Statins Reduced All-Cause Mortality, Amputation Risk in PAD
Higher doses of statins may more effectively prevent adverse clinical outcomes in PAD.
Rivaroxaban and Aspirin Dual Therapy for Peripheral Artery Disease
A meta-analysis of COMPASS and VOYAGER compared low-dose rivaroxaban and aspirin vs aspirin alone across a broad spectrum of patients with PAD.
- Loading...
Loading...
Next post in Vascular Medicine
Loading... 
Loading...